Form D · Other Technology
Pharma Analytics Holdings, LLC
Atlanta, GA · CIK 0001668090
Offering snapshot reported Mar 4, 2016 · SEC filing
- Reported sold
- $17.8M Offering amount: $17.8M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2016 | Initial | $17,754,777 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-258623
Source: Form D, filed Mar 4, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adi Filipovic | Director, Executive |
| Kevin Leininger | Director, Executive |
| Fred Sturgis | Director, Executive |
| Darren Weiss | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3284 Northside Parkway, Nw Suite 475
Atlanta, GA, 30327
Atlanta, GA, 30327